Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters

Database
Language
Document Type
Year range
1.
J Integr Med ; 19(2): 185-190, 2021 03.
Article in English | MEDLINE | ID: covidwho-957237

ABSTRACT

After one-month of oral treatment with traditional Chinese medicine decoction, without using other drugs, the lung inflammatory exudate, pulmonary fibrosis and quality of life of a 61-year-old female patient with corona virus disease 2019 (COVID-19) were significantly improved. No recurrence or deterioration of the patient's condition was found within seven weeks of treatment and follow-up, and no adverse events occurred, indicating that oral Chinese medicine decoction was able to improve the pulmonary inflammation and fibrosis in a patient recovering from COVID-19, but further research is still needed.


Subject(s)
COVID-19/complications , Drugs, Chinese Herbal/therapeutic use , Lung/drug effects , Medicine, Chinese Traditional , Phytotherapy , Pulmonary Fibrosis/drug therapy , Administration, Oral , COVID-19/virology , Exudates and Transudates , Female , Humans , Inflammation/drug therapy , Inflammation/etiology , Lung/pathology , Magnoliopsida , Middle Aged , Pulmonary Fibrosis/etiology , SARS-CoV-2
SELECTION OF CITATIONS
SEARCH DETAIL